Document is current
Any future updates will be listed below
-
Authors
Rivas, Verónica
González-Muñoz, Teresa
Albitre, Ángela
Lafarga, Vanesa
Delgado-Arévalo, Cristina
Mayor, Federico Jr
Penela, Petronila https://orcid.org/0000-0002-0434-4738
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI21-01834)
Consejería de Sanidad, Comunidad de Madrid (P2022/BMD-7209)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (PID2020-117218RB-I00, PID2020-117218RB-I00)
Comunidad de Madrid (P2022/BMD-7209)
- License Information
-
More Information
Article History
Received: 4 April 2024
Revised: 3 August 2024
Accepted: 9 August 2024
First Online: 29 August 2024
Competing interests
: The authors declare no competing interests.
: All authors have agreed on the contents of the manuscript.
: This article does not include any research involving humans or animals. Cell lines and adenoviral vector-based methods were performed in accordance with the guidelines and regulations for a type 2 confined use activity (authorization A/ES/20/96, CBMSO).
